Skip to main content
. 2022 Sep 1;13:962774. doi: 10.3389/fgene.2022.962774

FIGURE 2.

FIGURE 2

m6A modification dysfunction related diseases in the central nervous system. Abbreviations: AD (Alzheimer’s disease), PD (Parkinson’s disease), GBM (Glioblastoma), MDD (Major depressive disorder), Aβ (amyloid-β), Tau (Tau protein), mTOR (Mammalian target of rapamycin signaling pathway), Ephrin-B2 (erythropoietin-producing hepatocyte receptor-interacting-B2), MGMT (O6-methylguanine-DNA methyltransferase), APNG (alkylpurine-DNA-N-glycosylase), SRSF7 (Serine/arginine-rich splicing factor 7), pri-miR-10a (primary microRNA-10a), FOXM1 (transcription factor FOXM1), HK2 (Hexokinase 2), ADRB2 (Adrenoceptor beta 2), CaMKII (Calcium-calmodulin-dependent protein kinase II), CREB (cAMP response element-binding protein), miR-335 (microRNA-335), miR-421-3P (microRNA-421-3p).